Year 2019, Volume 4 , Issue 3, Pages 89 - 95 2019-12-31

Assessment of adherence to drug treatment and affecting factors among hypertensive patients
Hipertansif hastalarda ilaç tedavisine uyum ve etkileyen faktörlerin değerlendirilmesi

Burkay Yakar [1] , Asli Azakoglu Karaca [2] , Erhan Onalan [3]


Introduction: Adherence to antihypertensive therapy is important for blood pressure control. Poor adherence to antihypertensive drug therapy leads to the development of hypertensive complications and increase risk of cardiovascular events. The aim of this study was to assess adherence to antihypertensive drug therapy and associated factors among hypertensive patients.

Methods: A cross-sectional study was conducted on a simple random sample of 242 patients at the Family Health Center. Adherence to antihypertensive treatment was assessed using the Turkish Modified Morisky Scale (TMMS). The factors affecting the adherence to treatment were obtained with a sociodemographic questionnaire. Blood pressures of all participants were measured from both arms and the mean values were recorded.

Results: The mean age of the 242 participants was 60.95 ± 12.54 years. Mean systolic blood pressures of the participants were 139.08±20.78 mmHg and mean diastolic blood pressures were 83.63±11.88 mmHg. Adherence to antihypertensive medication was found 76.9% (non-adherence to treatment was 23.1%) and 75.6% of the participants had sufficient knowledge antihypertensive treatment.

Conclusions: We found numbers of drugs taken daily, level of knowledge about treatment and level of education to be the strongest factors affecting adherence to anti-hypertensive medication among our patients. We also found that high adherence to treatment is important for effective blood pressure control. Health workers' questioning the adherence to antihypertensive drug therapy may provide more effective blood pressure control in hypertensive patients.

Giriş: Antihipertansif tedaviye uyum kan basıncı kontrolü için önemlidir. Antihipertansif ilaç tedavisine zayıf uyum hipertansif komplikasyonların gelişmesine ve kardiyovasküler olay riskinin artmasına sebep olur. Çalışmamızın amacı hipertansif hastalarda antihipertansif ilaç tedavisine uyumu ve etkileyen faktörleri değerlendirmektir.

Yöntem: Aile Sağlığı Merkezinde 242 hastadan oluşan basit rastgele örneklem üzerinden kesitsel bir çalışma yürütülmüştür. Antihipertansif tedaviye uyumun değerlendirilmesinde Türkçe Modifiye Morisky Ölçeği kullanılmıştır. Tedaviye uyumu etkileyen faktörler sosyodemografik anket formu ile elde edilmiştir. Tüm katılımcıların kan basınçları her iki koldan ölçülüp ortalamaları kayıt edilmiştir.

Bulgular:  Çalışmaya dahil edilen 242 katılımcının yaş ortalaması 60,95±12,54 yıldı. Katılımcıların ortalama sistolik kan basıncı 139,08±20,78 mmHg, diyastolik kan basıncı ise 83,63±11,88 mmHg idi. Katılımcıların %75,6’sının antihipertansif tedavi bilgi düzeyi yeterli idi ve   antihipertansif tedaviye uyum oranı %76,9 (tedaviye uyumsuzluk oranı %23,1) saptandı.

Sonuç: Katılımcıların antihipertansif tedaviye uyumu günlük alınan ilaç sayısı, tedavi hakkında ki bilgi düzeyi ve eğitim düzeyleri ile ilişkili bulundu. Etkin kan basıncı kontrolünde tedaviye yüksek uyum önemliydi. Sağlık çalışanlarının hipertansif hastalarının antihipertansif tedaviye uyum durumunu sorgulamaları daha etkin kan basıncı kontrolü sağlayabilir.

  • 1. Naish J, Archbold A. The hypertension. In: The cardiovascular system, Naish J, Court DS (editors). Medical Sciences, 2nd ed. Philadelphia: Saunders Ltd; 2014:493-95.
  • 2. Xie L, Frech-Tamas F, Marrett E, Baser O. A medication adherence and persistence comparison of hypertensive patients treated with single-, double- and triple-pill combination therapy. Current Medical Research and Opinion 2014;30(12):2415-2. https://doi.org/10.1185/03007995.2014.964853
  • 3. Daugherty SL, Powers JD, Magid DJ, Tavel HM, Masoudi FA, Margolis KL, et al. Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation 2012; 125: 1635–2. https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.111.068064
  • 4. Calhoun DA, Booth JN, Oparil S, Irvin MR, Shimbo D, Lackland DT, et al. Refractory hypertension: determination of prevalence, risk factors, and comorbidities in a large, population-based cohort. Hypertension 2014; 63(3): 451-8. https://www.ahajournals.org/doi/10.1161/HYPERTENSIONAHA.113.02026
  • 5. Muntner P, Davis BR, Cushman WC, Bangalore S, Calhoun DA, Pressel SL, et al. Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). Hypertension 2014; 64: 1012–1. https://www.ahajournals.org/doi/10.1161/HYPERTENSIONAHA.114.03850
  • 6. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green Lee A, Izzo JL Jr, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003;42: 1206-2. https://www.ahajournals.org/doi/10.1161/01.HYP.0000107251.49515.c2
  • 7. Al-Ramahi R. Adherence to medications and associated factors: A cross-sectional study among Palestinian hypertensive patients. Journal of Epidemiology and Global Health 2015; 5(2): 125-2 .https://www.sciencedirect.com/science/article/pii/S2210600614000537?via%3Dihub
  • 8. Tomaszewski M, White C, Patel P, Masca N, Damani R, Hepworth J, et al. High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis. Heart 2014;100: 855-1. http://dx.doi.org/10.1136/heartjnl-2013-305063
  • 9. Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ 2006;333: 1-6. https://doi.org/10.1136/bmj.38875.675486.55
  • 10. Shin S, Song H, Oh SK, Choi KE, Jang S. Effect of antihypertensive medication adherence on hospitalization for cardiovascular disease and mortality in hypertensive patients. Hypertens Res 2013;36: 1000-5. https://doi.org/10.1038/hr.2013.85
  • 11. Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation 2009;119: 3028-5. https://doi.org/10.1161/CIRCULATIONAHA.108.768986
  • 12. Mert H, Özçakar N, Kuruoğlu E. [A multidisciplinary special study module research: treatment compliance of patients with hypertension] (in Turkish). Turk Aile Hek Derg. 2011;15(1): 7-12
  • 13. Esirgen L. [Development of the Evaluation Scale for Treatment Compliance and Life Change Success of Hypertensive Individuals] (in Turkish). Department of Public Health, Cerrahpaşa Faculty of Medicine, Istanbul University. Medical Specialty Thesis. Istanbul. 2018
  • 14. Kaya EP. [Evaluation of drug compliance of patients with hypertension.] (in Turkish). Department of Family Medicine, Ankara Atatürk Training and Research Hospital, Medical Specialty Thesis. Ankara. 2016.
  • 15. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353: 487-7. https://doi.org/10.1056/NEJMra050100
  • 16. Choi HY, Oh IJ, Lee JA, Lim J, Kim YS, Jeon TH et al. Factors Affecting Adherence to Antihypertensive Medication. Korean J Fam Med 2018; 39(6): 325–2. https://dx.doi.org/10.4082%2Fkjfm.17.0041
  • 17. Kim SJ, Kwon OD, Cho BL, Oh S-W, Lee CM, Choi HC. Effects of combination drugs on antihypertensive medication adherence in a realworld setting: a Korean Nationwide Study. BMJ Open 2019;9:e029862. http://dx.doi.org/10.1136/bmjopen-2019-029862
  • 18. Morisky DE, Green LW, Levine DM. Concurren tand predictive validity of a self-reported measure of medication adherence. Med Care 1986;24(1):67-4.
  • 19. Vuralı B, Acar ÖT, Topsever P, Filiz M. [Reliability And Validity Of Turkish Version Of Modified Morisky Scale] (in Turkish) Turkish Family Physcian 1999;3(4): 17-20
  • 20. Mallya SD, Kumar A, Kamath A, Shetty A, Reddy T Sravan K, Mishra S. Assessment of treatment adherence among hypertensive patients in a coastal area of Karnataka, India. Int J Community Med Public Health 2016;3(8): 1998-3 http://dx.doi.org/10.18203/2394-6040.ijcmph20162185
  • 21. Asgedom SW, Atey TM, Desse TA. Antihypertensive medication adherence and associated factors among adult hypertensive patients at Jimma University Specialized Hospital, southwest Ethiopia. BMC Res Notes 2018;11(27): 592-8 . https://doi.org/10.1186/s13104-018-3139-6
  • 22. Jae-Hyun Park, Youngsoo Shin, Sang-Yi Lee, Sang III LeeI. Antihypertensive drug medication adherence and its affecting factors in South Korea. International Journal of Cardiology 2008;128: 392-8. https://doi.org/10.1016/j.ijcard.2007.04.114
  • 23. Hashmi SK, Afridi MB, Abbas K, Sajwani RA, Saleheen D, Frossard PM, et al. Factors Associated with Adherence to Anti-Hypertensive Treatment in Pakistan. PLoS ONE 2007;3: 1-8. https://doi.org/10.1371/journal.pone.0000280
  • 24. Lulebo AM, Mutombo PB, Mapatano MA, Mafuta EM, Kayembe PK, Ntumba LT, et al. Predictors of non-adherence to antihypertensive medication in Kinshasa, Democratic Republic of Congo: a cross-sectional study. BMC research notes 2015; 8(1): 526-4. https://dx.doi.org/10.1186%2Fs13104-015-1519-8
  • 25. Ramli A, Ahmad NS, Paraidathathu T. Medication adherence among hypertensive patients of primary health clinics in Malaysia. Patient preference and adherence 2012; 6: 613-4. https://doi.org/10.2147/PPA.S34704
  • 26. Kim Y, Kong KA. Do hypertensive individuals who are aware of their disease follow lifestyle recommendations better than those who are not aware? PLoS ONE 2015;10(8): 1-13. https://doi.org/10.1371/journal.pone.0136858
  • 27. Uludag A, Sahin EM, Agaoglu H, Gungor S, Ertekin YH, Tekin M. Are blood pressure values compatible with medication adherence in hypertensive patients? Niger J Clin Pract 2016;19(4):460-4. https://doi.org/10.4103/1119-3077.180060
  • 28. Uchmanowicz B, Jankowska EA, Uchmanowicz I, Morisky DE. Self-Reported Medication Adherence Measured With Morisky Medication Adherence Scales and Its Determinants in Hypertensive Patients Aged _60 Years: A Systematic Review and Meta-Analysis. Front. Pharmacol 2019:10:(168): 1-11. https://doi.org/10.3389/fphar.2019.00168
  • 29. Schmieder RE, Ott C, Schmid A, Friedrich S, Kistner I, Ditting T, et al. Adherence to antihypertensive medication in treatment-resistant hypertension undergoing renal denervation. Am Heart Assoc. 2016;5:e002343 https://doi.org/10.1161/JAHA.115.002343
  • 30. Hayes P, Casey M, Glynn LG, Molloy GJ, Durand H, O’Brien E, et al. Measuring adherence to therapy in apparent treatment-resistant hypertension. British Journal of General Practice 2019;69(686): 621-28. https://doi.org/10.3399/bjgp19X705077
Primary Language en
Subjects Medicine
Published Date Dec 2019
Journal Section Original Research
Authors

Orcid: 0000-0003-2745-6561
Author: Burkay Yakar (Primary Author)
Institution: Department of Family Medicine, School of Medicine, Fırat University, Elazig
Country: Turkey


Orcid: 0000-0003-4742-8023
Author: Asli Azakoglu Karaca
Institution: Alanya Family Health Center No.1, Antalya
Country: Turkey


Orcid: 0000-0001-5395-0390
Author: Erhan Onalan
Institution: Department of Internal Medicine, School of Medicine, Fırat University, Elazig
Country: Turkey


Dates

Application Date : August 22, 2019
Acceptance Date : November 25, 2019
Publication Date : December 31, 2019

Bibtex @research article { fppc609576, journal = {Family Practice and Palliative Care}, issn = {2458-8865}, eissn = {2459-1505}, address = {}, publisher = {SERNEV}, year = {2019}, volume = {4}, pages = {89 - 95}, doi = {10.22391/fppc.609576}, title = {Assessment of adherence to drug treatment and affecting factors among hypertensive patients}, key = {cite}, author = {Yakar, Burkay and Azakoglu Karaca, Asli and Onalan, Erhan} }
APA Yakar, B , Azakoglu Karaca, A , Onalan, E . (2019). Assessment of adherence to drug treatment and affecting factors among hypertensive patients. Family Practice and Palliative Care , 4 (3) , 89-95 . DOI: 10.22391/fppc.609576
MLA Yakar, B , Azakoglu Karaca, A , Onalan, E . "Assessment of adherence to drug treatment and affecting factors among hypertensive patients". Family Practice and Palliative Care 4 (2019 ): 89-95 <http://www.fppc.com.tr/en/issue/50274/609576>
Chicago Yakar, B , Azakoglu Karaca, A , Onalan, E . "Assessment of adherence to drug treatment and affecting factors among hypertensive patients". Family Practice and Palliative Care 4 (2019 ): 89-95
RIS TY - JOUR T1 - Assessment of adherence to drug treatment and affecting factors among hypertensive patients AU - Burkay Yakar , Asli Azakoglu Karaca , Erhan Onalan Y1 - 2019 PY - 2019 N1 - doi: 10.22391/fppc.609576 DO - 10.22391/fppc.609576 T2 - Family Practice and Palliative Care JF - Journal JO - JOR SP - 89 EP - 95 VL - 4 IS - 3 SN - 2458-8865-2459-1505 M3 - doi: 10.22391/fppc.609576 UR - https://doi.org/10.22391/fppc.609576 Y2 - 2019 ER -
EndNote %0 Family Practice and Palliative Care Assessment of adherence to drug treatment and affecting factors among hypertensive patients %A Burkay Yakar , Asli Azakoglu Karaca , Erhan Onalan %T Assessment of adherence to drug treatment and affecting factors among hypertensive patients %D 2019 %J Family Practice and Palliative Care %P 2458-8865-2459-1505 %V 4 %N 3 %R doi: 10.22391/fppc.609576 %U 10.22391/fppc.609576
ISNAD Yakar, Burkay , Azakoglu Karaca, Asli , Onalan, Erhan . "Assessment of adherence to drug treatment and affecting factors among hypertensive patients". Family Practice and Palliative Care 4 / 3 (December 2020): 89-95 . https://doi.org/10.22391/fppc.609576
AMA Yakar B , Azakoglu Karaca A , Onalan E . Assessment of adherence to drug treatment and affecting factors among hypertensive patients. Fam Pract Palliat Care. 2019; 4(3): 89-95.
Vancouver Yakar B , Azakoglu Karaca A , Onalan E . Assessment of adherence to drug treatment and affecting factors among hypertensive patients. Family Practice and Palliative Care. 2019; 4(3): 95-89.